Literature DB >> 11892806

Monoclonal antibodies to human interferon-gamma: production, affinity purification and radioimmunoassay.

D Novick1, Z Eshhar, D G Fischer, J Friedlander, M Rubinstein.   

Abstract

Human interferon-gamma (IFN-gamma) purified to electrophoretic homogeneity by a cation exchange h.p.l.c., was used for the development of monoclonal antibodies. Following immunization, spleen lymphocytes of two mice showing the highest binding and neutralizing titers were isolated, fused with NSO mouse myeloma cells and cloned. The screening of hybridomas was based on precipitation of the immune complexes with a second antibody and recovery of the biological activity of IFN-gamma from the precipitate. Twenty nine independent hybridomas secreting antibodies specific to IFN-gamma were obtained. Twelve out of these 29 hybridomas produced antibodies that neutralized the antiviral activity of pure as well as crude IFN-gamma. Moreover, IFN-gamma obtained by various induction procedures was neutralized as well, indicating that these various IFN-gamma subtypes are immunologically cross-reactive. Immune precipitation of partially purified 125I-labelled IFN-gamma by several monoclonal antibodies revealed two protein bands of 26,000 and 21,000 daltons. Immunoaffinity chromatography of IFN-gamma gave a 50-fold purification to a specific activity > or = 4 x 10(7) units/mg. Two of the monoclonal antibodies were found suitable for a sensitive and rapid double antibody solid-phase radioimmunoassay, allowing the detection of IFN-gamma at concentrations of at least 4 ng/ml (150 units/ml) within 8 h.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 11892806      PMCID: PMC555317          DOI: 10.1002/j.1460-2075.1983.tb01618.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  19 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Polymers coupled to agarose as stable and high capacity spacers.

Authors:  M Wilchek; T Miron
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

5.  Interferon nomenclature.

Authors: 
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

6.  A monoclonal antibody for large-scale purification of human leukocyte interferon.

Authors:  D S Secher; D C Burke
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

7.  Monoclonal antibodies against human fibroblast interferon.

Authors:  H K Hochkeppel; U Menge; J Collins
Journal:  Nature       Date:  1981-06-11       Impact factor: 49.962

8.  Convenient assay for interferons.

Authors:  S Rubinstein; P C Familletti; S Pestka
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

9.  Generation of hybridomas secreting murine reaginic antibodies of anti-DNP specificity.

Authors:  Z Eshhar; M Ofarim; T Waks
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

10.  The cloning of normal "mast" cells in tissue culture.

Authors:  D H Pluznik; L Sachs
Journal:  J Cell Physiol       Date:  1965-12       Impact factor: 6.384

View more
  10 in total

1.  Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; J M McNally; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

2.  Interferons regulate the in vitro differentiation of multilineage lympho-myeloid stem cells in hairy cell leukemia.

Authors:  R Michalevicz; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

3.  Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy.

Authors:  D A Isenberg; D Rowe; M Shearer; D Novick; P C Beverley
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

4.  HLA class I and II, interferon, interleukin 2, and the interleukin 2 receptor expression on labial biopsy specimens from patients with Sjögren's syndrome.

Authors:  D Rowe; M Griffiths; J Stewart; D Novick; P C Beverley; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1987-08       Impact factor: 19.103

5.  IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma.

Authors:  L L Reznikov; S H Kim; J Y Westcott; J Frishman; G Fantuzzi; D Novick; M Rubinstein; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

6.  3' end structure of the human (2'-5') oligo A synthetase gene: prediction of two distinct proteins with cell type-specific expression.

Authors:  P Benech; G Merlin; M Revel; J Chebath
Journal:  Nucleic Acids Res       Date:  1985-02-25       Impact factor: 16.971

7.  Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.

Authors:  T W Chang; S McKinney; V Liu; P C Kung; J Vilcek; J Le
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein.

Authors:  T Hahn; L Toker; S Budilovsky; D Aderka; Z Eshhar; D Wallach
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines.

Authors:  A Zilberstein; R Ruggieri; J H Korn; M Revel
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

10.  Soluble cytokine receptors are present in normal human urine.

Authors:  D Novick; H Engelmann; D Wallach; M Rubinstein
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.